2018 Vol.36, N°4 - Suppl.113 - Table of contents
Scleroderma 2018
11th Annual Supplement on Systemic Sclerosis
Guest Editor: S. Bombardieri
One year in review
CER11750
2018,36,4,Suppl.113
Pg. 0003-0023
Free to view
One year in review 2018: systemic sclerosis
M. Orlandi, S. Barsotti, G. Lepri, V. Codullo, M. Di Battista, S. Guiducci, A. Della Rossa
M. Orlandi, S. Barsotti, G. Lepri, V. Codullo, M. Di Battista, S. Guiducci, A. Della Rossa
Aetiopathogenesis
CER10744
2018,36,4,Suppl.113
Pg. 0024-0027
Free to view
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis
A. Gigante, D. Margiotta, L. Navarini, M. Liberatori, B. Barbano, L. Tubani, A. Afeltra, E. Rosato
A. Gigante, D. Margiotta, L. Navarini, M. Liberatori, B. Barbano, L. Tubani, A. Afeltra, E. Rosato
CER10732
2018,36,4,Suppl.113
Pg. 0028-0035
Free to view
Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation
L. Glaeser, J. Henes, I. Kötter, W. Vogel, L. Kanz, R. Klein
L. Glaeser, J. Henes, I. Kötter, W. Vogel, L. Kanz, R. Klein
CER11208
2018,36,4,Suppl.113
Pg. 0036-0044
Free to view
Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts
S. Piera-Velazquez, S.A. Jimenez
S. Piera-Velazquez, S.A. Jimenez
CER11416
2018,36,4,Suppl.113
Pg. 0045-0049
Free to view
Dickkopf-1 is downregulated early and universally in the skin of patients with systemic sclerosis despite normal circulating levels
D. Daoussis, D.J. Papachristou, T. Dimitroulas, T. Sidiropoulos, I. Antonopoulos, A.P. Andonopoulos, S.-N. Liossis
D. Daoussis, D.J. Papachristou, T. Dimitroulas, T. Sidiropoulos, I. Antonopoulos, A.P. Andonopoulos, S.-N. Liossis
Clinical aspects
CER10843
2018,36,4,Suppl.113
Pg. 0050-0052
Free to view
Development of systemic sclerosis in transgender females: a case series and review of the literature
C. Campochiaro, L.V. Host, V.H. Ong, C.P. Denton
C. Campochiaro, L.V. Host, V.H. Ong, C.P. Denton
CER10745
2018,36,4,Suppl.113
Pg. 0053-0060
Free to view
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
K. Morrisroe, M. Hudson, M. Baron, J. De vries-Bouwstra, P.E. Carreira, D.M. Wuttge, M. Wang, T.M. Frech, W. Stevens, S.M. Proudman, M. Nikpour
for the International Systemic Sclerosis Inception Cohort (INSYNC) collaboration
K. Morrisroe, M. Hudson, M. Baron, J. De vries-Bouwstra, P.E. Carreira, D.M. Wuttge, M. Wang, T.M. Frech, W. Stevens, S.M. Proudman, M. Nikpour
for the International Systemic Sclerosis Inception Cohort (INSYNC) collaboration
CER11052
2018,36,4,Suppl.113
Pg. 0061-0067
Free to view
Effects of autonomic dysfunction on exercise tolerance in systemic sclerosis patients without clinical and instrumental evidence of cardiac and pulmonary involvement
M. Di Paolo, A. Gigante, M. Liberatori, L. Sardo, P. Marinelli, M. Rossetti, P. Palange, L. Tubani, E. Rosato
M. Di Paolo, A. Gigante, M. Liberatori, L. Sardo, P. Marinelli, M. Rossetti, P. Palange, L. Tubani, E. Rosato
CER10523
2018,36,4,Suppl.113
Pg. 0068-0075
Free to view
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database
P.E. Carreira, L. Carmona, B.E. Joven, E. Loza, J.L. Andreu, G. Riemekasten, S. Vettori, A. Balbir-Gurman, P. Airò, U.A. Walker, N. Damjanov, M. Matucci-Cerinic, L.P. Ananieva, S. Rednic, L. Czirják, O. Distler, D. Farge, R. Hesselstrand, A. Corrado, P. Caramaschi, M. Tikly, Y. Allanore
and the EUSTAR co-authors
P.E. Carreira, L. Carmona, B.E. Joven, E. Loza, J.L. Andreu, G. Riemekasten, S. Vettori, A. Balbir-Gurman, P. Airò, U.A. Walker, N. Damjanov, M. Matucci-Cerinic, L.P. Ananieva, S. Rednic, L. Czirják, O. Distler, D. Farge, R. Hesselstrand, A. Corrado, P. Caramaschi, M. Tikly, Y. Allanore
and the EUSTAR co-authors
CER11036
2018,36,4,Suppl.113
Pg. 0076-0081
Free to view
Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis
R. Apipattarakul, C. Foocharoen, S. Netwijitpan, A. Mahakkanukrauh, S. Suwannaroj, P. Limpawattana, R. Nanagara
R. Apipattarakul, C. Foocharoen, S. Netwijitpan, A. Mahakkanukrauh, S. Suwannaroj, P. Limpawattana, R. Nanagara
CER11205
2018,36,4,Suppl.113
Pg. 0082-0087
Free to view
From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey
M. Vasile, J. Avouac, I. Sciarra, K. Stefanantoni, N. Iannace, E. Cravotto, G. Valesini, Y. Allanore, V. Riccieri
M. Vasile, J. Avouac, I. Sciarra, K. Stefanantoni, N. Iannace, E. Cravotto, G. Valesini, Y. Allanore, V. Riccieri
CER11301
2018,36,4,Suppl.113
Pg. 0088-0094
Free to view
The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study
L. Kwakkenbos, T.A. Sanchez, K.A. Turner, L. Mouthon, M.-E. Carrier, M. Hudson, C.H. Van Den Ende, A.A. Schouffoer, J.J. Welling, M. Sauvé, B.D. Thombs
and the SPIN Investigators
L. Kwakkenbos, T.A. Sanchez, K.A. Turner, L. Mouthon, M.-E. Carrier, M. Hudson, C.H. Van Den Ende, A.A. Schouffoer, J.J. Welling, M. Sauvé, B.D. Thombs
and the SPIN Investigators
Diagnosis
CER10935
2018,36,4,Suppl.113
Pg. 0095-0101
Free to view
A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients
E. Vandecasteele, K. Melsens, F. De Keyser, M. De Pauw, E. Deschepper, S. Decuman, Y. Piette, K. Thevissen, G. Brusselle, V. Smith
E. Vandecasteele, K. Melsens, F. De Keyser, M. De Pauw, E. Deschepper, S. Decuman, Y. Piette, K. Thevissen, G. Brusselle, V. Smith
CER10806
2018,36,4,Suppl.113
Pg. 0102-0108
Free to view
Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function
S.-Y. Kawashiri, A. Nishino, T. Igawa, A. Takatani, T. Shimizu, M. Umeda, S. Fukui, A. Okada, T. Suzuki, T. Koga, N. Iwamoto, K. Ichinose, M. Tamai, M. Nakashima, A. Mizokami, N. Matsuoka, K. Migita, F. Ogawa, S. Ikeda, K. Maemura, H. Nakamura, T. Origuchi, T. Maeda, A. Kawakami
S.-Y. Kawashiri, A. Nishino, T. Igawa, A. Takatani, T. Shimizu, M. Umeda, S. Fukui, A. Okada, T. Suzuki, T. Koga, N. Iwamoto, K. Ichinose, M. Tamai, M. Nakashima, A. Mizokami, N. Matsuoka, K. Migita, F. Ogawa, S. Ikeda, K. Maemura, H. Nakamura, T. Origuchi, T. Maeda, A. Kawakami
CER10950
2018,36,4,Suppl.113
Pg. 0109-0117
Free to view
To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?
M. Boonstra, B.J. Mertens, J.A. Bakker, M.K. Ninaber, N. Ajmone Marsan, A.H. Van der helm-Van mil, H.U. Scherer, T.W. Huizinga, J.K. De vries-Bouwstra
M. Boonstra, B.J. Mertens, J.A. Bakker, M.K. Ninaber, N. Ajmone Marsan, A.H. Van der helm-Van mil, H.U. Scherer, T.W. Huizinga, J.K. De vries-Bouwstra
CER10934
2018,36,4,Suppl.113
Pg. 0118-0125
Free to view
Quantification of skin stiffness in patients with systemic sclerosis using real-time shear wave elastography: a preliminary study
Y. Yang, F. Yan, L. Wang, X. Xiang, Y. Tang, Q. Li, L. Xiaoyan
Y. Yang, F. Yan, L. Wang, X. Xiang, Y. Tang, Q. Li, L. Xiaoyan
CER11443
2018,36,4,Suppl.113
Pg. 0126-0134
Free to view
The role of inflammatory markers in assessment of disease activity in systemic sclerosis
L. Ross, W. Stevens, C. Rabusa, M. Wilson, N. Ferdowsi, J. Walker, J. Sahhar, G.-S. Ngian, J. Zochling, J. Roddy, K. Tymms, G. Major, G. Strickland, S.M. Proudman, M. Nikpour
L. Ross, W. Stevens, C. Rabusa, M. Wilson, N. Ferdowsi, J. Walker, J. Sahhar, G.-S. Ngian, J. Zochling, J. Roddy, K. Tymms, G. Major, G. Strickland, S.M. Proudman, M. Nikpour
Treatment
CER10370
2018,36,4,Suppl.113
Pg. 0135-0141
Free to view
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction
G. Fiori, T. Marzi, F. Bartoli, C. Bruni, C. Ciceroni, M. Palomba, M. Zolferino, E. Corsi, M. Galimberti, A. Moggi Pignone, M.P. Viggiano, S. Guiducci, M. Calamai, M. Matucci-Cerinic
G. Fiori, T. Marzi, F. Bartoli, C. Bruni, C. Ciceroni, M. Palomba, M. Zolferino, E. Corsi, M. Galimberti, A. Moggi Pignone, M.P. Viggiano, S. Guiducci, M. Calamai, M. Matucci-Cerinic
CER11343
2018,36,4,Suppl.113
Pg. 0142-0145
Free to view
Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study
P. Fraticelli, C. Fischetti, F. Salaffi, M. Carotti, M. Mattioli, G. Pomponio, A. Gabrielli
P. Fraticelli, C. Fischetti, F. Salaffi, M. Carotti, M. Mattioli, G. Pomponio, A. Gabrielli
CER11243
2018,36,4,Suppl.113
Pg. 0146-0149
Free to view
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial
J.C. Mantero, N. Kishore, J. Ziemek, G. Stifano, C. Zammitti, D. Khanna, J.K. Gordon, R. Spiera, Y. Zhang, R.W. Simms, R. Lafyatis
J.C. Mantero, N. Kishore, J. Ziemek, G. Stifano, C. Zammitti, D. Khanna, J.K. Gordon, R. Spiera, Y. Zhang, R.W. Simms, R. Lafyatis
Reviews
CER10677
2018,36,4,Suppl.113
Pg. 0150-0160
Free to view
Fatigue in systemic sclerosis: a systematic review
F. Basta, A. Afeltra, D.P.E. Margiotta
F. Basta, A. Afeltra, D.P.E. Margiotta
CER11105
2018,36,4,Suppl.113
Pg. 0161-0167
Free to view
Usefulness of six-minute walk test in systemic sclerosis
M. Rizzi, D. Radovanovic, P. Santus, A. Airoldi, F. Frassanito, S. Vanni, A. Cristiano, P. Sarzi-Puttini, F. Atzeni
M. Rizzi, D. Radovanovic, P. Santus, A. Airoldi, F. Frassanito, S. Vanni, A. Cristiano, P. Sarzi-Puttini, F. Atzeni
CER10986
2018,36,4,Suppl.113
Pg. 0168-0174
Free to view
Helicobacter pylori infection in systemic sclerosis: a systematic review and meta-analysis of observational studies
W.C. Yong, S. Upala, A. Sanguankeo
W.C. Yong, S. Upala, A. Sanguankeo
CER11407
2018,36,4,Suppl.113
Pg. 0175-0182
Free to view
Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment
T.M. Frech, D.R. Machin, M.A. Murtaugh, G.J. Stoddard, S.I. Bloom, J.V. Phibbs, A.J. Donato
DOI: https://doi.org/10.55563/clinexprheumatol/7ulgbj
T.M. Frech, D.R. Machin, M.A. Murtaugh, G.J. Stoddard, S.I. Bloom, J.V. Phibbs, A.J. Donato
DOI: https://doi.org/10.55563/clinexprheumatol/7ulgbj
Letters to the Editor
CER10983
2018,36,4,Suppl.113
Pg. 0183
Free to view
Autologous fat transfer in the successful treatment of upper limb linear morphoea
S. Mura, A. Fin, P.C. Parodi, C.P. Denton, K.J. Howell, E. Rampino Cordaro
S. Mura, A. Fin, P.C. Parodi, C.P. Denton, K.J. Howell, E. Rampino Cordaro
CER10931
2018,36,4,Suppl.113
Pg. 0184-0185
Free to view
The novel adipokine C1q-TNF related protein 9 (CTRP9) is elevated in systemic sclerosis-associated interstitial lung disease
B. Korman, R. Alejo, D. Sudhakar, M. Hinchcliff, R. Agrawal, J. Varga, R.G. Marangoni
B. Korman, R. Alejo, D. Sudhakar, M. Hinchcliff, R. Agrawal, J. Varga, R.G. Marangoni
CER11185
2018,36,4,Suppl.113
Pg. 0186
Free to view
Survival of connective tissue disease associated pulmonary arterial hypertension
A.P. Luppino Assad, F. Gavilanes Oleas, J.L. Alves, Jr, C.J.C. Dos Santos Fernandes, P.D. Sampaio-Barros, R. Souza
A.P. Luppino Assad, F. Gavilanes Oleas, J.L. Alves, Jr, C.J.C. Dos Santos Fernandes, P.D. Sampaio-Barros, R. Souza